Cargando…
Study design considerations for irritable bowel syndrome clinical trials
Clinical trials of therapies intended to alleviate symptoms of irritable bowel syndrome (IBS) are prevalent. However, the ideal study design remains elusive since there is no obvious pathophysiological target and no universally accepted endpoint to assess symptom improvement in IBS. The purpose of t...
Autor principal: | Miller, Larry E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4188930/ https://www.ncbi.nlm.nih.gov/pubmed/25330749 |
Ejemplares similares
-
Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome
por: Shah, Eric, et al.
Publicado: (2014) -
Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015) -
The epidemiology of irritable bowel syndrome
por: Canavan, Caroline, et al.
Publicado: (2014) -
Diet in irritable bowel syndrome
por: El-Salhy, Magdy, et al.
Publicado: (2015) -
Biomarkers of Irritable Bowel Syndrome
por: Kim, Jae Hak, et al.
Publicado: (2017)